As drug discovery teams turn back to phenotypic screening in the hopes of improving lead identification, high-content imaging (HCI) is becoming the method of choice for secondary compound screens and even primary screens with smaller, directed libraries. But these systems are optimized for adherent cells, leaving researchers who are focused on suspension cells, such as immune cells, with either low-throughput methods like flow cytometry and microscopy, or low-content methods like plate readers. In addition, high-end HCI systems can be expensive, finicky, and complicated to use, with long per-plate data acquisition times.
The iQue Screener is filling this gap by enabling high-throughput high-content screening of suspension cells. Easily screen large libraries formatted in 96-, 384- or 1536-well plates, generating rich, multi-readout datasets in a fraction of the time that a high-end high-content imaging system takes. Get the data you need to prioritize compounds and move your discovery program into high gear with the iQue Screener.